Position in COGT
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$43,430,880
+$32,211,586 QoQ
Shares Held
1,122,245
+285.0% QoQ
Ownership
0.647%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#37
of 323 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in COGT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. COGT ranks #41 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
5,450,825 | $1,020,369,609 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
17,466,641 | $618,144,423 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
3,399,221 | $416,676,508 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
712,259 | $353,800,411 | |
| 5 | MRNA |
Moderna, Inc.
|
4,463,211 | $312,558,664 | |
| 6 | INSM |
INSMED Inc
|
2,584,446 | $275,553,630 | |
| 7 | ABVX |
Abivax S.A.
|
1,844,918 | $245,853,771 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
401,708 | $215,697,109 |
All Filings in COGT
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $43,430,880 | 1,122,245 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $11,219,294 | 291,486 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $9,378,949 | 264,047 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $26,618,729 | 1,853,672 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $25,264,057 | 3,518,671 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $18,593,737 | 3,104,130 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,668,685 | 213,934 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,247,345 | 115,495 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,066,723 | 126,539 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,896,353 | 431,005 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,337,152 | 227,407 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $770,971 | 79,074 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $976,503 | 82,475 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,002,929 | 92,950 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $2,509,490 | 217,084 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $486,869 | 32,632 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $4,951 | 549 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $3,138 | 419 | Shares | Sole | 2022-05-16 | |
| 2021-09-30 | $2,169 | 258 | Shares | Sole | 2021-11-15 | |
| 2020-09-30 UMRX | — | 340 | Shares | Sole | 2020-11-12 | |
| 2020-03-31 UMRX | — | 8,475 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||